Vanda Pharmaceuticals, Inc. (VNDA) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.95 -0.83%
EPS Growth %: -30.4%
Financial Fact:
Research and development: 7.29M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -30.4%
Financial Fact:
Research and development: 7.29M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q3 EPS of ($0.19), $0.08 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $8.3 million versus the consensus estimate of $8.3 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Cerebras Q1 EPS miss sends shares down 9% after-hours
- Obsidian Energy Increases Syndicated Credit Facility
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
